PA5-41961

antibody from Invitrogen Antibodies

Targeting: HNRNPA3 HNRPA3

Western blot (Data presented on provider website)

Immunohistochemistry (Data presented on provider website)

Other assay (Supportive data in Antibodypedia)

Antibody Data

Product number

PA5-41961

Provider

Invitrogen Antibodies

Product name

hnRNP A3 Polyclonal Antibody

Antibody type

Polyclonal

Antigen

Synthetic peptide

Description

Peptide sequence: MEVKPPPGRP QPDSGRRRRR RGEEGHDPKE PEQLRKLFIG GLSFETTDDS Sequence homology: Cow: 100%; Dog: 100%; Guinea Pig: 100%; Human: 100%; Mouse: 100%; Rabbit: 100%; Rat: 100%

Reactivity

Human

Host

Rabbit

Isotype

IgG

Vial size

100 µL

Concentration

1 mg/mL

Storage

-20° C, Avoid Freeze/Thaw Cycles

References

Submitted references

Alterations of Asymmetric Dimethylarginine (ADMA)-Containing Protein Profiles Associated with Chronic Pancreatitis Pathogenesis.

Tan C, Xiao Y, Huang X, Wu L, Huang Y
Journal of inflammation research 2021;14:7381-7392

Other assay

Supportive validation

Submitted by

Invitrogen Antibodies (provider)

Main image

Experimental details

Figure 5 HNRNPA3 dimethylation and its correlation with inflammatory factors. ( A ) Greatly increased asymmetric arginine dimethylation of HNRNPA3 proteins in CP tissues. Protein asymmetric arginine dimethylation were quantitatively assessed by immunoprecipitation using antibodies targeting ADMA, followed by Western blot with the antibodies specifically recognizing HNRNPA3 ( B ). Relative HNRNPA3 dimethylation levels among four CP patients were compared with the control group containing four other cholangiocarcinoma patients. ( C , D and E ) The positive correlation of HNRNPA3 asymmetric arginine dimethylation levels with the major inflammatory factors in serum of CP patients. Serum TGF-b, TNF-a and IL-6 levels in CP patients were analyzed via ELISA method. *P